NO20091441L - Rekonstituerte surfaktanter med forbedrede egenskaper - Google Patents

Rekonstituerte surfaktanter med forbedrede egenskaper

Info

Publication number
NO20091441L
NO20091441L NO20091441A NO20091441A NO20091441L NO 20091441 L NO20091441 L NO 20091441L NO 20091441 A NO20091441 A NO 20091441A NO 20091441 A NO20091441 A NO 20091441A NO 20091441 L NO20091441 L NO 20091441L
Authority
NO
Norway
Prior art keywords
improved properties
reconstituted surfactants
reconstituted
original
surfactants
Prior art date
Application number
NO20091441A
Other languages
English (en)
Other versions
NO342038B1 (no
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091441(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20091441L publication Critical patent/NO20091441L/no
Publication of NO342038B1 publication Critical patent/NO342038B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

Den foreliggende oppfinnelsen retter seg mot en rekonstituert surfaktant omfattende en lipidbærer, en polypeptidanalog av opprinnelig surfaktantprotein SP-C, og en polypeptidanalog av det opprinnelige surfaktantproteinet SP-B. Oppfinnelsen retter seg også mot de farmasøytiske sammensetningene derav og til deres bruk for behandling eller profylakse av RDS og andre respiratoriske lidelser.
NO20091441A 2006-10-13 2009-04-14 Rekonstituerte surfaktanter med forbedrede egenskaper NO342038B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13
PCT/IB2007/002841 WO2008044109A1 (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Publications (2)

Publication Number Publication Date
NO20091441L true NO20091441L (no) 2009-06-23
NO342038B1 NO342038B1 (no) 2018-03-19

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091441A NO342038B1 (no) 2006-10-13 2009-04-14 Rekonstituerte surfaktanter med forbedrede egenskaper

Country Status (35)

Country Link
US (2) US8183210B2 (no)
EP (1) EP2078038B1 (no)
JP (2) JP5405307B2 (no)
KR (1) KR101328851B1 (no)
CN (2) CN103169947B (no)
AR (2) AR063263A1 (no)
AU (1) AU2007306075B2 (no)
BR (1) BRPI0715317B1 (no)
CA (1) CA2666344C (no)
CL (1) CL2007002931A1 (no)
CO (1) CO6400235A2 (no)
CY (1) CY1114716T1 (no)
DK (1) DK2078038T3 (no)
EA (1) EA015802B1 (no)
ES (1) ES2438727T3 (no)
GE (1) GEP20125531B (no)
HR (1) HRP20140052T1 (no)
IL (1) IL198075A (no)
JO (1) JO2963B1 (no)
MA (1) MA31062B1 (no)
ME (2) ME02326B (no)
MX (1) MX343064B (no)
MY (1) MY148127A (no)
NO (1) NO342038B1 (no)
NZ (1) NZ576189A (no)
PE (1) PE20081184A1 (no)
PL (1) PL2078038T3 (no)
PT (1) PT2078038E (no)
RS (1) RS53172B (no)
SI (1) SI2078038T1 (no)
TN (1) TN2009000099A1 (no)
TW (1) TWI388333B (no)
UA (1) UA94477C2 (no)
WO (1) WO2008044109A1 (no)
ZA (1) ZA200902481B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
EP3459556A1 (en) 2012-02-09 2019-03-27 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Synthetic analogs of lung surfactant protein sp-c and their use
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
EP2922868B1 (en) * 2012-11-21 2017-09-27 Chiesi Farmaceutici S.p.A. Reconstituted pulmonary surfactants
US10717777B2 (en) 2015-12-17 2020-07-21 The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
EP3452041B1 (en) 2016-03-07 2026-01-14 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Compositions and methods for administering ppar-gamma-agonists, surfactant peptides and phospholipids
RU2748417C2 (ru) 2016-08-24 2021-05-25 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Стабильная фармацевтическая композиция, включающая восстановленную композицию легочного сурфактанта
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
WO2022082082A2 (en) * 2020-10-16 2022-04-21 Sherwood Russ Lehrman Lung treatment compositions
WO2025024609A1 (en) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163860A1 (en) * 1993-06-30 1995-01-12 Chung C. Hsu Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) * 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
ZA200902481B (en) 2010-07-28
AR113422A2 (es) 2020-04-29
PE20081184A1 (es) 2008-09-26
PT2078038E (pt) 2013-12-12
ES2438727T3 (es) 2014-01-20
BRPI0715317B1 (pt) 2021-10-05
MY148127A (en) 2013-02-28
AR063263A1 (es) 2009-01-14
IL198075A (en) 2016-04-21
EA015802B1 (ru) 2011-12-30
GEP20125531B (en) 2012-05-25
EP2078038A1 (en) 2009-07-15
ME02326B (me) 2016-06-20
CY1114716T1 (el) 2016-10-05
TW200824705A (en) 2008-06-16
UA94477C2 (ru) 2011-05-10
EP2078038B1 (en) 2013-11-20
CA2666344A1 (en) 2008-04-17
US8183210B2 (en) 2012-05-22
WO2008044109A1 (en) 2008-04-17
MX2009003638A (es) 2009-04-22
US20130079275A1 (en) 2013-03-28
NO342038B1 (no) 2018-03-19
TN2009000099A1 (en) 2010-08-19
SI2078038T1 (sl) 2014-02-28
MX343064B (es) 2016-10-24
IL198075A0 (en) 2011-08-01
JP5405307B2 (ja) 2014-02-05
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
US20100004173A1 (en) 2010-01-07
HRP20140052T1 (hr) 2014-02-28
CN101522711B (zh) 2013-11-13
MA31062B1 (fr) 2010-01-04
CA2666344C (en) 2017-04-18
KR20090083892A (ko) 2009-08-04
US9238058B2 (en) 2016-01-19
NZ576189A (en) 2011-09-30
EA200900373A1 (ru) 2009-10-30
JP2013241449A (ja) 2013-12-05
RS53172B (sr) 2014-06-30
TWI388333B (zh) 2013-03-11
PL2078038T3 (pl) 2014-05-30
CN101522711A (zh) 2009-09-02
MEP12109A (en) 2011-12-20
CL2007002931A1 (es) 2008-03-24
HK1134497A1 (en) 2010-04-30
BRPI0715317A2 (pt) 2013-07-09
JO2963B1 (en) 2016-03-15
KR101328851B1 (ko) 2013-11-14
AU2007306075B2 (en) 2012-08-09
JP2010505937A (ja) 2010-02-25
CN103169947A (zh) 2013-06-26
AU2007306075A1 (en) 2008-04-17
DK2078038T3 (da) 2013-12-02
HK1185274A1 (en) 2014-02-14

Similar Documents

Publication Publication Date Title
TN2009000099A1 (en) Reconstituted surfactants having improved properties
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
JO3226B1 (ar) مخفف توتر سطحي معاد التشكيل مطور يحتوي على نظائر بروتين مخفف للتوتر السطحي b(sp-b) وبروتين مخفف للتوتر السطحي c (sp-c)
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
SG163517A1 (en) Antiviral compounds and methods
NO20083501L (no) Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
MX2010008206A (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf.
MX391339B (es) Composicion farmaceutica que comprende selexipag.
BRPI0813699A2 (pt) Formulações de proteína de fusão glp-1-fc
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
EP2166845A4 (en) ALPHA CONNEXIN C TERMINAL (ACT) PEPTIDES FOR THE TREATMENT OF AGE-RELATED MACULAR AGENCY
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
MX2010001543A (es) Peptidos de surfactante pulmonar sintetico.
DE602005020639D1 (de) Zusammensetzung aus milchsäure und lactoferrin
AU2017221784B2 (en) Novel compositions and methods for the treatment of immune related diseases
UY31131A1 (es) "oxazolidinonas sustituidas y su uso
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE422905T1 (de) Verbandsmaterial mit wirkstoffen
DE602005011661D1 (de) Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen
TN2010000348A1 (en) Methods and compositions using klotho-fgf fusion polypeptides